These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4053710)

  • 1. Daily vs alternate day prednisone therapy for stage II sarcoidosis.
    Spratling L; Tenholder MF; Underwood GH; Feaster BL; Requa RK
    Chest; 1985 Nov; 88(5):687-90. PubMed ID: 4053710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternate day steroid therapy in diffuse pulmonary sarcoidosis.
    Block AJ; Light RW
    Chest; 1973 Apr; 63(4):495-504. PubMed ID: 4695345
    [No Abstract]   [Full Text] [Related]  

  • 3. Corticosteroid therapy of pulmonary sarcoidosis. A prospective evaluation of alternate day and daily dosage in stage II disease.
    Selroos O; Sellergren TL
    Scand J Respir Dis; 1979 Aug; 60(4):215-21. PubMed ID: 531541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathophysiology and response to steroid therapy in sarcoidosis.
    Ploysongsang Y; Roberts RD
    Respiration; 1986; 49(3):204-15. PubMed ID: 3961284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary sarcoidosis. Long-term follow-up of the effects of steroid therapy.
    Harkleroad LE; Young RL; Savage PJ; Jenkins DW; Lordon RE
    Chest; 1982 Jul; 82(1):84-7. PubMed ID: 7044709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of the effectiveness of budesonide and prednisone in the maintenance treatment of pulmonary sarcoidosis].
    Zych D; Pawlicka L; Zieliński J
    Pol Arch Med Wewn; 1992 Jul; 88(1):30-7. PubMed ID: 1454657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcoidosis: a correlation of dyspnea with roentgenographic stage and pulmonary function changes.
    DeRemee RA; Andersen HA
    Mayo Clin Proc; 1974 Oct; 49(10):742-5. PubMed ID: 4422825
    [No Abstract]   [Full Text] [Related]  

  • 8. [Bronchoalveolar lavage (BAL) in pulmonary sarcoidosis. II. Changes in BAL cellular morphology and respiratory function in patients with sarcoidosis treated with prednisone].
    Ziora D; Oklek K
    Pneumonol Alergol Pol; 1993; 61(3-4):159-65. PubMed ID: 8364431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial changes in markers of disease activity with corticosteroid treatment in sarcoidosis.
    Lawrence EC; Teague RB; Gottlieb MS; Jhingran SG; Lieberman J
    Am J Med; 1983 May; 74(5):747-56. PubMed ID: 6301276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Course of pulmonary sarcoidosis with and without corticosteriod therapy as determined by pulmonary function studies.
    Sharma OP; Colp C; Williams MH
    Am J Med; 1966 Oct; 41(4):541-51. PubMed ID: 5923597
    [No Abstract]   [Full Text] [Related]  

  • 11. Airway function in sarcoidosis: effect of short-term steroid therapy.
    Renzi GD; Renzi PM; Lopez-Majano V; Dutton RE
    Respiration; 1981; 42(2):98-104. PubMed ID: 7313337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The sequence of physiologic changes in pulmonary sarcoidosis: correlation with radiographic stages and response to therapy.
    Miller A; Teirstein AS; Chuang MT
    Mt Sinai J Med; 1977; 44(6):852-65. PubMed ID: 304172
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic value of bronchoalveolar lavage lymphocyte count in recently diagnosed pulmonary sarcoidosis.
    Laviolette M; La Forge J; Tennina S; Boulet LP
    Chest; 1991 Aug; 100(2):380-4. PubMed ID: 1864110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended experience in the long-term corticosteroid treatment of pulmonary sarcoidosis.
    Johns CJ; Macgregor MI; Zachary JB; Ball WC
    Ann N Y Acad Sci; 1976; 278():722-31. PubMed ID: 1067052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary sarcoidosis: a prospective evaluation of glucocorticoid therapy.
    Young RL; Harkleroad LE; Lordon RE; Weg JG
    Ann Intern Med; 1970 Aug; 73(2):207-12. PubMed ID: 5454257
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term study of pulmonary sarcoidosis. The effect of steroid therapy as evaluated by pulmonary function studies.
    Emirgil C; Sobol BJ; Williams MH
    J Chronic Dis; 1969 Jul; 22(2):69-86. PubMed ID: 5795890
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparison of 3 times weekly versus daily corticosteroid administration in sarcoidosis. A prospective, randomized multicenter study of the Scientific Society for the Therapy of Lung Diseases].
    Kropp R; Goebel D; Matthiessen W; Goetzke A; Forschbach G; Radenbach KL; Wentz D
    Prax Klin Pneumol; 1986 Apr; 40(4):123-8. PubMed ID: 3520536
    [No Abstract]   [Full Text] [Related]  

  • 18. Methotrexate as a single agent for treating pulmonary sarcoidosis: a single centre real-life prospective study.
    Goljan-Geremek A; Bednarek M; Franczuk M; Puścińska E; Nowiński A; Czystowska M; Kamiński D; Korzybski D; Stokłosa A; Kowalska A; Wojda E; Sliwiński P; Burakowska B; Ptak J; Barańska I; Drygalska A; Małek G; Bestry I; Wesołowski S; Kram M; Górecka D
    Pneumonol Alergol Pol; 2014; 82(6):518-33. PubMed ID: 25339562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled budesonide in pulmonary sarcoidosis: a double-blind, placebo-controlled study. Dutch Study Group on Pulmonary Sarcoidosis.
    Alberts C; van der Mark TW; Jansen HM
    Eur Respir J; 1995 May; 8(5):682-8. PubMed ID: 7656936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis for sarcoidosis in a defined geographical area.
    Huhti E; Poukkula A; Lilja M
    Br J Dis Chest; 1987 Oct; 81(4):381-90. PubMed ID: 3449122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.